-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, IlibbD2RAmdtgP3of3KcaXt4A8qtVUjzf0ncHKXPcLScy4vaGUnNvq2QOSxbWdBF Xe+qvt7WFl7GWcD3UgJ7UQ== 0001225208-08-016308.txt : 20081016 0001225208-08-016308.hdr.sgml : 20081016 20081016161400 ACCESSION NUMBER: 0001225208-08-016308 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20081014 FILED AS OF DATE: 20081016 DATE AS OF CHANGE: 20081016 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE BOSTON SCIENTIFIC PL CITY: NATICK STATE: MA ZIP: 01760-1537 BUSINESS PHONE: 5086508000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NICHOLAS PETER M CENTRAL INDEX KEY: 0000901458 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11083 FILM NUMBER: 081127507 BUSINESS ADDRESS: STREET 1: C/O BOSTON SCIENTIFIC CORP STREET 2: ONE BOSTON SCIENTIFIC PLACE CITY: NATICK STATE: MA ZIP: 01760-1537 BUSINESS PHONE: 5086508567 MAIL ADDRESS: STREET 1: C/O BOSTON SCIENTIFIC CORPORATION STREET 2: ONE BOSTON SCIENTIFIC PLACE CITY: NATICK STATE: MA ZIP: 01760-1537 4 1 doc4.xml X0303 4 2008-10-14 0000885725 BOSTON SCIENTIFIC CORP BSX 0000901458 NICHOLAS PETER M ONE BOSTON SCIENTIFIC PLACE NATICK MA 01760-1537 1 Common Stock 2008-10-14 4 S 0 805625 9.32 D 37322630 I By Ltd. Partnership Common Stock 2008-10-15 4 S 0 194375 9.38 D 37128255 I By Ltd. Partnership Common Stock 15302846 D Common Stock 2413088 I By Trust 2 The transactions reported on this Form 4 represent the automatic involuntary sale of Boston Scientific common stock. These shares were previously pledged to collateralize a loan. The weighted average sales price is reported as stock sales were aggregated for reporting purposes. The per share transaction price ranged from $9.03 to $9.52. The reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices. The weighted average sales price is reported as stock sales were aggregated for reporting purposes. The per share transaction price ranged from $9.16 to $9.60. The reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices. Shares held by trust of which the reporting person's spouse and brother are trustees and the reporting person's spouse and children are beneficiaries. /s/ Lawrence J. Knopf, Attorney-in-fact 2008-10-16 -----END PRIVACY-ENHANCED MESSAGE-----